Similar articles for PMID: 31871779

Year	Number of Results
2006	3
2007	2
2008	2
2009	2
2010	3
2012	1
2013	6
2014	4
2015	6
2016	8
2017	8
2018	7
2019	11
2020	7
2021	15
2022	13
2023	14
2024	0

1

Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Cheng Y, He C, Wang M, Ma X, Mo F, Yang S, Han J, Wei X. Cheng Y, et al. Signal Transduct Target Ther. 2019 Dec 17;4:62. doi: 10.1038/s41392-019-0095-0. eCollection 2019. Signal Transduct Target Ther. 2019. PMID: 31871779 Free PMC article. Review.

2

Histone Demethylase Modulation: Epigenetic Strategy to Combat Cancer Progression.

Srivastava R, Singh R, Jauhari S, Lodhi N, Srivastava R. Srivastava R, et al. Epigenomes. 2023 May 17;7(2):10. doi: 10.3390/epigenomes7020010. Epigenomes. 2023. PMID: 37218871 Free PMC article. Review.

3

Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond.

Feng J, Meng X. Feng J, et al. Front Pharmacol. 2022 Sep 15;13:946811. doi: 10.3389/fphar.2022.946811. eCollection 2022. Front Pharmacol. 2022. PMID: 36188615 Free PMC article. Review.

4

Epigenetic Targets and their Inhibitors in Cancer Therapy.

Zhao L, Duan YT, Lu P, Zhang ZJ, Zheng XK, Wang JL, Feng WS. Zhao L, et al. Curr Top Med Chem. 2018;18(28):2395-2419. doi: 10.2174/1568026619666181224095449. Curr Top Med Chem. 2018. PMID: 30582481 Review.

5

Relationship between High Expression of Kaiso Protein and Poor Prognosis of Lung Cancer and the Regulation Mechanism of Malignant Phenotype of Lung Cancer Cells.

Zhu S, Zhou N, Ding N, Li S, Liu X, Ren G, Li Q, Zhou M. Zhu S, et al. J Oncol. 2021 Dec 22;2021:7388368. doi: 10.1155/2021/7388368. eCollection 2021. J Oncol. 2021. PMID: 34976058 Free PMC article.

6

Epigenetic Enzyme Mutations: Role in Tumorigenesis and Molecular Inhibitors.

Han M, Jia L, Lv W, Wang L, Cui W. Han M, et al. Front Oncol. 2019 Mar 29;9:194. doi: 10.3389/fonc.2019.00194. eCollection 2019. Front Oncol. 2019. PMID: 30984620 Free PMC article. Review.

7

Targeting epigenetic DNA and histone modifications to treat kidney disease.

Fontecha-Barriuso M, Martin-Sanchez D, Ruiz-Andres O, Poveda J, Sanchez-Niño MD, Valiño-Rivas L, Ruiz-Ortega M, Ortiz A, Sanz AB. Fontecha-Barriuso M, et al. Nephrol Dial Transplant. 2018 Nov 1;33(11):1875-1886. doi: 10.1093/ndt/gfy009. Nephrol Dial Transplant. 2018. PMID: 29534238 Review.

8

Insights into novel emerging epigenetic drugs in myeloid malignancies.

Chandhok NS, Prebet T. Chandhok NS, et al. Ther Adv Hematol. 2019 Aug 6;10:2040620719866081. doi: 10.1177/2040620719866081. eCollection 2019. Ther Adv Hematol. 2019. PMID: 31431820 Free PMC article. Review.

9

Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.

Falahi F, van Kruchten M, Martinet N, Hospers GA, Rots MG. Falahi F, et al. Breast Cancer Res. 2014 Jul 29;16(4):412. doi: 10.1186/s13058-014-0412-z. Breast Cancer Res. 2014. PMID: 25410383 Free PMC article. Review.

10

Targeting Epigenetic Regulators for Endometrial Cancer Therapy: Its Molecular Biology and Potential Clinical Applications.

Inoue F, Sone K, Toyohara Y, Takahashi Y, Kukita A, Hara A, Taguchi A, Tanikawa M, Tsuruga T, Osuga Y. Inoue F, et al. Int J Mol Sci. 2021 Feb 25;22(5):2305. doi: 10.3390/ijms22052305. Int J Mol Sci. 2021. PMID: 33669072 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year